Evidence map›Paper›PMID 29516533›Full record

ArticleBritish journal of clinical pharmacology2018

Prevalence of exceeding maximum daily dose of paracetamol, and seasonal variations in cold-flu season.

Saul Shiffman, Deena R Battista, Judith P Kelly, Mary K Malone, Rachel B Weinstein, David W Kaufman

Open access · bronzeAbstract read
In one paragraph

Article in British journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. The Over-the-Counter Medicines Market in Poland.International journal of environmental research and public health · 2022
    Article
  3. Impact of acetaminophen product labelling changes in Canada on hospital admissions for accidental acetaminophen overdose: a population-based study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  4. Article
  5. Paracetamol: A Review of Guideline Recommendations.Journal of clinical medicine · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Saul ShiffmanPinney Associates, Pittsburgh, PA, USA.ORCID 0000-0002-9639-490X
Deena R BattistaPinney Associates, Pittsburgh, PA, USA.
Judith P KellySlone Epidemiology Center at Boston University, Boston, MA, USA.
Mary K MaloneAppleseed Consumer Insight, Arlington, MA, USA.
Rachel B WeinsteinJanssen Research & Development, LLC, Titusville, NJ, USA.
David W KaufmanSlone Epidemiology Center at Boston University, Boston, MA, USA.
Boston University · USApple (United States) · USJanssen (United States) · USPinney Associates (United States)University of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo estimate prevalence of excess intake of paracetamol and investigate seasonal variations therein.

methodsBetween 2011 and 2016, 14 481 US adults who used paracetamol in the preceding 30 days were sampled from national online panels and completed a detailed online daily diary of paracetamol medication use for 7 days. Respondents were not told that the study concerned paracetamol. Cold/flu season (CFS), identified using Google Trends data, was contrasted to off-season in symptoms, use of paracetamol medications, and consumption exceeding 4 g (the recommended daily maximum).

resultsOverall, 6.3% [95% confidence interval: 5.9-6.7%] of users exceeded 4 g on at least one day; 3.7% [3.5-3.8%] of usage days exceeded 4 g. Cold/flu symptoms were more likely to be experienced and treated with paracetamol in CFS than off-season. Paracetamol users were more likely to exceed 4 g during CFS (6.5% vs. 5.3%; odds ratio = 1.24, 1.04-1.48); days exceeding 4 g also increased (3.9% vs. 2.8%; odds ratio = 1.37, 1.11-1.69). This was not due to differences in characteristics of individuals using paracetamol in CFS, but primarily to increased use of over-the-counter combination medications designed to treat upper respiratory cold/flu symptoms (33.2% of usage days in CFS vs. 24.8% in off-season; odds ratio = 1.58, 1.46-1.72). When such medications were omitted, there was no statistically significant seasonal variation in exceeding 4 g.

conclusionsParacetamol use and over-dosing increases in CFS, primarily due to increased use of over-the-counter combinations treating upper respiratory cold/flu symptoms. Pharmacists should warn users to follow labelled dosing directions, especially during CFS.

Indexed as

Drug MisuseSeasonsAcetaminophenAnalgesics, Non-NarcoticCommon ColdDose-Response Relationship, DrugDrug Dosage CalculationsDrug LabelingHumansInfluenza, HumanNonprescription DrugsPrescription Drug MisusePrescription DrugsRisk FactorsTime FactorsTreatment OutcomeAcetaminophenAnalgesics, Non-NarcoticNonprescription DrugsPrescription Drugscoldcombination productsflunonprescriptionparacetamolseasonality

Identifiers

PMID29516533
PMCPMC5980528
OpenAlexW2792625131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.